GLP1R and type 2 diabetes mellitus: Although our findings may support the use of GLP-1 RAs as first-line type 2 diabetes treatment for the prevention of DR, further research such as a randomized clinical trial study with a longer follow-up time is warranted to establish more robust evidence.